GSK vs HYSR · P/E 13, $103.31B cap vs rev $1.3K
GlaxoSmithKline PLC ADR (GSK) versus SunHydrogen Inc. (HYSR) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
SunHydrogen Inc. (HYSR) is a solar company listed on PINK.
GSK does not have a complete income-statement cache yet.
Latest reported HYSR revenue for 2026-03-31 was $1.3K. Net income was -$4.6M. Revenue was up 0.0% from 2025-12-31 to 2026-03-31. HYSR currently screens at market cap $128.3M.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. HYSR currently screens at market cap $128.3M.
Not investment advice. Open the GSK and HYSR stock pages for the full models.
Not investment advice.